Академический Документы
Профессиональный Документы
Культура Документы
IgE-
616-002-092:612.112.92.06:577.175.85 (048.8)
1 (115) 2010
-
,
, 350063, . , . , 4. E-mail: troickaya@rambler.ru
48
IgE- , , . IgE
, .
in vitro IgE- IgE
- -4.
IgE- .
: , , IgE, , , IgE- .
, IgE-
-
(Th2) (-4, -13) [11, 12],
IgE - [8].
,
Th2 IgE c
Th1/Th2- .
()
[7, 9],
[2, 3, 4, 5].
(),
.
IgE
- [6], Th1/Th2- [3].
in vivo ( , ) in vitro (
IgE- ) .
IgE- in vivo
in vivo 80
,
4 ./ IgE. 4 :
12- 34- .
(4 / ), 10 ( 3)
15- ( 4) IgE-.
,
, , , 10- ( 1) 15- ( 2)
, .
- IgE-
. Levin [10].
1:2 0,05 . 24
(20 ./) 0,2 1%-
,
. 30
,
IgE- .
- ,
.
m,
, m
.
Excell 2002 ( MS,
). Statiatica 6.0 for Windows ( StatSoft, ).
IgE in vivo
IgE-
10- (1,58+
0,30 ), 15- IgE-
(1,060,09),
().
24
10-
( IgE)
IgE-
(0,440,03). IgE 15-
(0,670,08
0,440,03) ().
IgE- Ig, -4 -
in
vitro .
, in vitro
IgE
IgE- ().
in vitro
- -4 ().
-4 - .
1 (115) 2010
IgE (-4, -)
in vitro
IgE-
() 12 , , 12
.
8
12 IgE- ,
.
6 --: , , 3
; 6 , 3 , 4 ,
. .
IgE
150 450 /.
.
Ig , (, ), ( ).
-6
- (1077-78) (Pharmacia, ).
0,1%-
(Serva).
:
75%, 25%,
0,5%.
199 RPMI 1640,
2 L-, 10 Hepes (
Serva, ) 10%- 40 / .
IgE
96 200
150 , 2-,
5% 2, 96%- 37
6 , (-4
-) 3 .
IgE
IgE, -4 - - (Pharmacia).
IgE 104
105 . ,
105
200 .
, IgE- , -
[1], .
IgE ,
,
24 , 10- 15-
. ,
IgE- in vitro
49
1 (115) 2010
50
IgE- ,
:
-10 IgE 10-
,
-15 IgE 15-
,
+-10 IgE 10-
,
+-15 IgE 15-
()
IgE
(/)
g-
(/)
-4
(/)
IgE
(/)
3,12
0,56
20,56
1,24
7,30
1,14
3,27
0,59
9,58
1,25
11,72
0,11
18,35
1,87
6,02
0,70
<0,01
IgE- . in vitro
, -
-4 ,
Th1 Th2
Th1. , in vitro - ,
[5].
IgE-
, -
g-
(/)
22,93
1,31
<0,01
13,91
0,77
<0,01
-4
(/)
6,96
1,91
8,46
1,85
<0,001
Th1- Th2- .
1. . ., . ., . ., . .,
. . // . 2008. 34
(102103) . 113117.
2. . . :
// Int. J. Immunorehab. 1998. 10. . 1928.
3. . . // . . 1-
. , 1992. . 328.
4. . ., P. M. // . 1996. 8. . 712.
5. . ., . ., . . //
. ., 2005.
. 1936.
6. . . () // . 1994. 2. . 4750.
7. Adam A. Moden concepts in immunology // Ed. C. A. Bona.
New Jork, 1985. 1. P. 31.
8. Kapsenberg M. L., Hikens C. M., Wierenga E. A. et all. The role
of antigen-prezenting cells in the regulation of allergen-specific T-cell
responses // Curr. Opin. Immunol. 1998. 10. P. 607613.
20.12.2009
. . 1, . . 2
,
,
, 350063, . , . , 4. E-mail: Olga-Kompaniets1@yandex.ru
1
-
, , .
, , .
: , - , - , .
O. G. Kompaniets1, V. M. Pokrovskii2
1 (115) 2010
1-
-
1
Department of clinical pharmacology,
department of normal physiology Kuban state medical university
Russia, 350063, Krasnodar city, Sedina st., 4. E-mail: Olga-Kompaniets1@yandex.ru
2
Doksazozin has impaird functional and adaptive abilities of patients with arterial hypertension, which was revealed in decrease
of cardiorespiratory synchronisation range of cardiac and respiratory rhythms, and increase of the duration of synchronisation
development at the minimum limit of synchronization range. The indicated changes were observed during acute pharmacological test,
after four weeks and six months of treatment, despite of the achievement of normal arterial pressure.
Key words: doksazozin, cardiorespiratory synchronism, functional and adaptive abilities, arterial hypertension.
, , ,
, - ,
, .
[7]. ,
, . - - (),
616.12-008.331.1-08:615.22
- /
, [2, 29]. ,
,
[1, 5].
[6, 8, 11, 18, 19, 22, 23, 33].
,
51